Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Cerebrolysin clinical trials
18 selected ClinicalTrials.gov records carrying the official matched intervention Cerebrolysin (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
18 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 26 selected PubMed records and 0 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT00840671
PeptideScanner retained ClinicalTrials.gov record NCT00840671 at 2026-11-16T17:33:14.861Z. Its registry update date was 2010-12-28, and PeptideScanner's reviewed identity mapping was cerebrolysin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- December 28, 2010
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00868283
PeptideScanner retained ClinicalTrials.gov record NCT00868283 at 2026-11-16T17:33:14.861Z. Its registry update date was 2023-12-15, and PeptideScanner's reviewed identity mapping was cerebrolysin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- December 15, 2023
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00947531
PeptideScanner retained ClinicalTrials.gov record NCT00947531 at 2026-11-16T17:33:14.861Z. Its registry update date was 2024-02-21, and PeptideScanner's reviewed identity mapping was cerebrolysin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- February 21, 2024
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Cerebrolysin · 2026-09-29
ClinicalTrials.gov record NCT07846488
Not yet recruiting at the retained observation.
Open attributed record →Cerebrolysin · 2026-08-11
ClinicalTrials.gov record NCT06339411
Not yet recruiting at the retained observation.
Open attributed record →Cerebrolysin · 2026-05-11
ClinicalTrials.gov record NCT04427241
Recruiting at the retained observation.
Open attributed record →Cerebrolysin · 2025-11-19
ClinicalTrials.gov record NCT06052787
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2025-07-31
ClinicalTrials.gov record NCT05821075
Recruiting at the retained observation.
Open attributed record →Cerebrolysin · 2025-02-25
ClinicalTrials.gov record NCT03480698
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2025-02-25
ClinicalTrials.gov record NCT05755997
Active, not recruiting at the retained observation.
Open attributed record →Cerebrolysin · 2024-12-31
ClinicalTrials.gov record NCT06677502
Enrolling by invitation at the retained observation.
Open attributed record →Cerebrolysin · 2024-08-05
ClinicalTrials.gov record NCT06208540
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2024-02-21
ClinicalTrials.gov record NCT00947531
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2023-12-15
ClinicalTrials.gov record NCT00868283
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2023-04-11
ClinicalTrials.gov record NCT05807503
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2023-01-03
ClinicalTrials.gov record NCT04830943
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2022-03-21
ClinicalTrials.gov record NCT05288465
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2021-03-15
ClinicalTrials.gov record NCT03506841
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2020-08-24
ClinicalTrials.gov record NCT02149875
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2019-09-20
ClinicalTrials.gov record NCT02768571
Completed at the retained observation.
Open attributed record →Cerebrolysin · 2010-12-28
ClinicalTrials.gov record NCT00840671
Completed at the retained observation.
Open attributed record →